The Biotech Growth Trust PLC (BIOG) — Cash Flow-to-Debt Ratio
The Biotech Growth Trust PLC (BIOG) has a Cash Flow-to-Debt Ratio of -0.08x as of September 2025, meaning its operating cash flow of GBX-2.52 Million could theoretically repay 0% of its total liabilities (GBX32.10 Million) in one year. See BIOG free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
The Biotech Growth Trust PLC Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for The Biotech Growth Trust PLC across 14 annual periods. Also explore The Biotech Growth Trust PLC net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for The Biotech Growth Trust PLC (2012–2025)
Year-by-year debt coverage analysis for The Biotech Growth Trust PLC. For market capitalisation and broader financial context, see BIOG company net worth.
| Year | CF-to-Debt Ratio | Operating CF (GBX) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.94x | GBX-5.09 Million | GBX5.42 Million | ▼ -1008.4% |
| 2024 | -0.08x | GBX-4.24 Million | GBX50.11 Million | ▲ +56.6% |
| 2023 | -0.19x | GBX-5.89 Million | GBX30.22 Million | ▲ +46.6% |
| 2022 | -0.37x | GBX-12.14 Million | GBX33.24 Million | ▼ -209.4% |
| 2021 | -0.12x | GBX-5.67 Million | GBX48.06 Million | ▼ -11.7% |
| 2020 | -0.11x | GBX-3.77 Million | GBX35.62 Million | ▲ +46.3% |
| 2019 | -0.20x | GBX-4.40 Million | GBX22.36 Million | ▼ -37.5% |
| 2018 | -0.14x | GBX-4.11 Million | GBX28.68 Million | ▲ +64.6% |
| 2017 | -0.40x | GBX-5.29 Million | GBX13.08 Million | ▼ -218.5% |
| 2016 | -0.13x | GBX-5.91 Million | GBX46.58 Million | ▼ -1060.3% |
| 2015 | 0.01x | GBX703.00K | GBX53.23 Million | ▲ +101.0% |
| 2014 | -1.30x | GBX-52.25 Million | GBX40.19 Million | ▼ -2603.2% |
| 2013 | 0.05x | GBX1.15 Million | GBX22.22 Million | ▲ +167.9% |
| 2012 | -0.08x | GBX-439.00K | GBX5.74 Million | — |